Information Journal Paper
APA:
CopyMIYAKE, H., HARA, I., & GLEAVE, M.E.. (2005). ANTISENSE OLIGODEOXYNUCLEOTIDE THERAPY TARGETING CLUSTERIN GENE FOR PROSTATE CANCER: VANCOUVER EXPERIENCE FROM DISCOVERY TO CLINIC. INTERNATIONAL JOURNAL OF UROLOGY, 12(9), 785-794. SID. https://sid.ir/paper/688950/en
Vancouver:
CopyMIYAKE H., HARA I., GLEAVE M.E.. ANTISENSE OLIGODEOXYNUCLEOTIDE THERAPY TARGETING CLUSTERIN GENE FOR PROSTATE CANCER: VANCOUVER EXPERIENCE FROM DISCOVERY TO CLINIC. INTERNATIONAL JOURNAL OF UROLOGY[Internet]. 2005;12(9):785-794. Available from: https://sid.ir/paper/688950/en
IEEE:
CopyH. MIYAKE, I. HARA, and M.E. GLEAVE, “ANTISENSE OLIGODEOXYNUCLEOTIDE THERAPY TARGETING CLUSTERIN GENE FOR PROSTATE CANCER: VANCOUVER EXPERIENCE FROM DISCOVERY TO CLINIC,” INTERNATIONAL JOURNAL OF UROLOGY, vol. 12, no. 9, pp. 785–794, 2005, [Online]. Available: https://sid.ir/paper/688950/en